Document Detail


Comparative efficiency and hemorheological consequences of hemotransfusion and epoetin therapy in anemic cancer patients.
MedLine Citation:
PMID:  20203366     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The aim of our study was to compare hemorheological consequences of hemotransfusion and recombinant human erythropoetin treatment in anemic cancer patients. Forty anemic patients with solid nonmyeloid malignancies were enrolled in this prospective, open-label study. Both prior to and following treatment (epoetin beta, 10,000 units subcutaneously thrice weekly, for four weeks and transfusion of 400 ml of erythrocyte mass) hemorheological measurements including blood and plasma viscosity, hematocrit (Hct), hemoglobin, red blood cell aggregation (RBCA) and deformability were completed. It was found an increase of Hb from 76.07+/-3.68 g/l to 87.86+/-4.26 g/l after the transfusion. It was accompanied by Hct rise by 25% (from 23.67+/-1.85 to 29.50+/-1.96%, p<0.05). Under these conditions the whole blood viscosity (BV) was increased by 19% (p<0.05). Plasma viscosity did not change markedly. Therefore the main cause of the whole blood viscosity rise was an increase of Hct. After erythrocyte mass transfusion there were some increases of red cell deformability and aggregation (by 7%, p>0.05). Under these conditions the Hct/BV ratio as an index of oxygen transport efficiency was changed after transfusion only slightly. While after four weeks of epoetin treatment the hematocrit/viscosity ratio was raised by 14% (p<0.05), in spite of the high blood viscosity. In addition RBCA decreased (p<0.01) and their deformability was increased by 14% (p<0.05). In vitro microrheological data permit to suggest that epoetin has a direct effect on the microrheological properties of red cells due to activation of the cellular signal transduction system including the tyrosine kinases and phosphatases. Thus, Epoetin beta administered s.c. thrice weekly, during four weeks, increased hemoglobin levels, improved hemorheological profile and especially its microrheological part as well as the blood transport capacity in anemic cancer patients who were receiving chemotherapy and its hemorheological effect was more positive than under hemotransfusion.
Authors:
A V Muravyov; S V Cheporov; N V Kislov; S V Bulaeva; A A Maimistova
Related Documents :
12138356 - A new ultrasound principle for characterizing erythrocyte aggregation: in vitro reprodu...
6612686 - Increase in blood viscosity due to alcohol drinking.
10560806 - Influence of hematocrit on hemostasis in continuous venovenous hemofiltration during ac...
7224236 - Influence of non-selective and selective beta adrenoceptor blockade on isoxsuprine-depe...
21189876 - Management of foetal asphyxia by intrauterine foetal resuscitation.
17477946 - Characterization of blood cells and hematological parameters in cichlasoma dimerus (tel...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical hemorheology and microcirculation     Volume:  44     ISSN:  1875-8622     ISO Abbreviation:  Clin. Hemorheol. Microcirc.     Publication Date:  2010  
Date Detail:
Created Date:  2010-03-05     Completed Date:  2010-06-18     Revised Date:  2010-06-24    
Medline Journal Info:
Nlm Unique ID:  9709206     Medline TA:  Clin Hemorheol Microcirc     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  115-23     Citation Subset:  IM    
Affiliation:
State Pedagogical University, Yaroslavl, Russia. alexei.47@mail.ru
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anemia / blood,  drug therapy,  therapy*
Blood Transfusion / methods*
Blood Viscosity
Erythrocytes / drug effects,  pathology
Erythropoietin, Recombinant / therapeutic use*
Hemoglobins / metabolism
Hemorheology
Humans
Middle Aged
Neoplasms / blood*
Pilot Projects
Prospective Studies
Signal Transduction
Chemical
Reg. No./Substance:
0/Erythropoietin, Recombinant; 0/Hemoglobins; 0/epoetin beta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Echinocytosis in athletes with exercise-induced hypoxemia.
Next Document:  Effect of vitamin E on reperfusion injuries during reconstructive vascular operations on lower limbs...